iFANN
    iFANN 검색...
    로그인
    홈
    뉴스
    동영상
    사진
    GIF
    탐색
    투표
    어워드
    iFAMOUS
    위키
    애니
    룸
    알림
    메시지
    북마크
    프로필
    위키어워드iFAMOUS랭킹산업크리에이터 리워드사용자 리워드약관개인정보커뮤니티 가이드라인게시 중단 / DMCA도움말개발자

    © 2026 iFANN

    홈
    검색
    메시지
    알림
    프로필

    게시물

    Gloriaunhinged
    Gloriaunhinged@gloriaunhinged
    💭Health💭Science

    CARv3-TEAM-E glioblastoma trial MRI results

    What showed up on the scans five days after one infusion is the part doctors are still calling jaw-dropping. Three people with recurrent glioblastoma came to Massachusetts General Hospital in early 2024, and the therapy they got, CARv3-TEAM-E, is a CAR T-cell approach that starts with each patient's own immune cells. Those cells get genetically rewired in the lab so they recognize two markers that tend to sit on glioblastoma cells. Then they go straight into the fluid spaces of the brain, and it all happens through one procedure. From there the outcomes split in ways nobody was ready for. One patient's MRI at day five showed the tumor had nearly vanished. Another patient's tumor shrank by more than 60 percent, and that reduction held for over six months. The third patient had clear tumor reduction within days. Compare that with what immunotherapy had done for this type of brain cancer before, and the speed and the size of the response are on another level entirely. The early images being described as jaw-dropping feels less like hype and more like an understatement.

    1mo

    521 좋아요31 싫어요84 리포스트24 댓글
    ?

    댓글

    아직 댓글이 없습니다. 첫 댓글을 남겨보세요!

    게시물

    Gloriaunhinged
    Gloriaunhinged@gloriaunhinged
    💭Health💭Science

    CARv3-TEAM-E glioblastoma trial MRI results

    What showed up on the scans five days after one infusion is the part doctors are still calling jaw-dropping. Three people with recurrent glioblastoma came to Massachusetts General Hospital in early 2024, and the therapy they got, CARv3-TEAM-E, is a CAR T-cell approach that starts with each patient's own immune cells. Those cells get genetically rewired in the lab so they recognize two markers that tend to sit on glioblastoma cells. Then they go straight into the fluid spaces of the brain, and it all happens through one procedure. From there the outcomes split in ways nobody was ready for. One patient's MRI at day five showed the tumor had nearly vanished. Another patient's tumor shrank by more than 60 percent, and that reduction held for over six months. The third patient had clear tumor reduction within days. Compare that with what immunotherapy had done for this type of brain cancer before, and the speed and the size of the response are on another level entirely. The early images being described as jaw-dropping feels less like hype and more like an understatement.

    1mo

    521 좋아요31 싫어요84 리포스트24 댓글
    ?

    댓글

    아직 댓글이 없습니다. 첫 댓글을 남겨보세요!